Dr Luke Harris Porsi, MD | |
113 Lielmanis Ave, Hurlburt Field, FL 32544-5613 | |
(850) 881-2337 | |
(850) 881-2323 |
Full Name | Dr Luke Harris Porsi |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Experience | 18 Years |
Location | 113 Lielmanis Ave, Hurlburt Field, Florida |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215125117 | NPI | - | NPPES |
1724923 | Medicaid | AK |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2083A0100X | Preventive Medicine - Aerospace Medicine | 01063919A (Indiana) | Secondary |
207P00000X | Emergency Medicine | 100863 (Alaska) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Central Peninsula General Hospital | Soldotna, AK | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Central Peninsula General Hospital Inc | 4587552575 | 85 |
News Archive
The way hospitals care for patients who have deliberately harmed themselves varies widely across England, according to new research from the University of Bristol published in the BMJ today.
COVID-19 is now the third leading cause of death in the United States only behind cardiovascular disease and cancer.
Children who experience trauma, abuse, neglect and family dysfunction are at increased risk of having heart disease in their 50s and 60s, according to a new Northwestern Medicine study.
Every year in the United States, thousands of high-risk fracture patients who have been admitted to trauma centers will suffer life-threatening blood clots related to the fracture. In rare cases these clots can even travel to the lungs, where they can cause sudden death.
Neogenix Oncology announced today that the U.S. Patent and Trade Mark Office has issued a Notice of Allowance for a patent application related to its 16C3 antibody. Discovered and developed by Neogenix Oncology, this antibody appears to have anti-tumor activity for both pancreatic and colorectal tumors, and may have both therapeutic and diagnostic utility. The antibody may have activity in other tumors as well, which the company will explore at such time as it prepares a pre-IND package for FDA review and designs a clinical trial for the 16C3 antibody.
› Verified 2 days ago
Entity Name | Central Peninsula General Hospital Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1528062429 PECOS PAC ID: 4587552575 Enrollment ID: O20040310000598 |
News Archive
The way hospitals care for patients who have deliberately harmed themselves varies widely across England, according to new research from the University of Bristol published in the BMJ today.
COVID-19 is now the third leading cause of death in the United States only behind cardiovascular disease and cancer.
Children who experience trauma, abuse, neglect and family dysfunction are at increased risk of having heart disease in their 50s and 60s, according to a new Northwestern Medicine study.
Every year in the United States, thousands of high-risk fracture patients who have been admitted to trauma centers will suffer life-threatening blood clots related to the fracture. In rare cases these clots can even travel to the lungs, where they can cause sudden death.
Neogenix Oncology announced today that the U.S. Patent and Trade Mark Office has issued a Notice of Allowance for a patent application related to its 16C3 antibody. Discovered and developed by Neogenix Oncology, this antibody appears to have anti-tumor activity for both pancreatic and colorectal tumors, and may have both therapeutic and diagnostic utility. The antibody may have activity in other tumors as well, which the company will explore at such time as it prepares a pre-IND package for FDA review and designs a clinical trial for the 16C3 antibody.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Luke Harris Porsi, MD 2740 Pala Dura Dr, Henderson, NV 89074-1999 Ph: (210) 288-6346 | Dr Luke Harris Porsi, MD 113 Lielmanis Ave, Hurlburt Field, FL 32544-5613 Ph: (850) 881-2337 |
News Archive
The way hospitals care for patients who have deliberately harmed themselves varies widely across England, according to new research from the University of Bristol published in the BMJ today.
COVID-19 is now the third leading cause of death in the United States only behind cardiovascular disease and cancer.
Children who experience trauma, abuse, neglect and family dysfunction are at increased risk of having heart disease in their 50s and 60s, according to a new Northwestern Medicine study.
Every year in the United States, thousands of high-risk fracture patients who have been admitted to trauma centers will suffer life-threatening blood clots related to the fracture. In rare cases these clots can even travel to the lungs, where they can cause sudden death.
Neogenix Oncology announced today that the U.S. Patent and Trade Mark Office has issued a Notice of Allowance for a patent application related to its 16C3 antibody. Discovered and developed by Neogenix Oncology, this antibody appears to have anti-tumor activity for both pancreatic and colorectal tumors, and may have both therapeutic and diagnostic utility. The antibody may have activity in other tumors as well, which the company will explore at such time as it prepares a pre-IND package for FDA review and designs a clinical trial for the 16C3 antibody.
› Verified 2 days ago
Anar J Patel, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 113 Lielmanis Ave, Hurlburt Field, FL 32544 Phone: 850-881-2129 | |
Caleb Robert Overfelt, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 225 Bennett Ave, Hurlburt Field, FL 32544 Phone: 850-884-1100 | |
Benjamin Jacob Mitchell, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 113 Lielmanis Ave, 1 Somdg, Hurlburt Field, FL 32544 Phone: 850-881-2337 Fax: 850-881-2323 | |
Meghan Tape, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 113 Lielmanis Ave, Hurlburt Field, FL 32544 Phone: 850-881-2129 |